Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 49 | 2024 | 17352 | 1.830 |
Why?
|
Pregnancy Complications, Infectious | 19 | 2024 | 2151 | 1.640 |
Why?
|
Anti-HIV Agents | 22 | 2024 | 4527 | 1.410 |
Why?
|
Infectious Disease Transmission, Vertical | 17 | 2024 | 1351 | 1.400 |
Why?
|
Oxazines | 7 | 2024 | 350 | 1.010 |
Why?
|
Heterocyclic Compounds, 3-Ring | 7 | 2024 | 287 | 0.940 |
Why?
|
Breast Feeding | 10 | 2024 | 1360 | 0.910 |
Why?
|
Anti-Retroviral Agents | 9 | 2024 | 1784 | 0.840 |
Why?
|
Pyridones | 7 | 2024 | 809 | 0.690 |
Why?
|
Piperazines | 7 | 2024 | 2523 | 0.570 |
Why?
|
Postpartum Period | 7 | 2024 | 1173 | 0.550 |
Why?
|
Viral Load | 11 | 2023 | 3332 | 0.520 |
Why?
|
HIV-1 | 11 | 2024 | 6863 | 0.490 |
Why?
|
Premature Birth | 5 | 2024 | 1782 | 0.460 |
Why?
|
CD4 Lymphocyte Count | 9 | 2021 | 2571 | 0.440 |
Why?
|
Pregnancy | 32 | 2024 | 29876 | 0.400 |
Why?
|
RNA, Viral | 3 | 2019 | 2846 | 0.380 |
Why?
|
Zidovudine | 5 | 2024 | 624 | 0.330 |
Why?
|
Benzoxazines | 3 | 2024 | 316 | 0.310 |
Why?
|
Alkynes | 2 | 2024 | 320 | 0.280 |
Why?
|
Cyclopropanes | 2 | 2024 | 432 | 0.260 |
Why?
|
Genes, BRCA2 | 3 | 2012 | 601 | 0.220 |
Why?
|
Serologic Tests | 2 | 2022 | 381 | 0.210 |
Why?
|
Genes, BRCA1 | 3 | 2012 | 764 | 0.210 |
Why?
|
Infant, Newborn | 18 | 2024 | 26198 | 0.210 |
Why?
|
Infant | 16 | 2024 | 36192 | 0.210 |
Why?
|
Milk, Human | 2 | 2024 | 486 | 0.200 |
Why?
|
Adenine | 3 | 2024 | 987 | 0.200 |
Why?
|
South Africa | 2 | 2024 | 1843 | 0.190 |
Why?
|
Female | 51 | 2024 | 392686 | 0.190 |
Why?
|
Drug Resistance, Viral | 2 | 2024 | 862 | 0.190 |
Why?
|
Antiretroviral Therapy, Highly Active | 5 | 2024 | 1897 | 0.180 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2024 | 1039 | 0.180 |
Why?
|
HIV Protease Inhibitors | 1 | 2022 | 432 | 0.170 |
Why?
|
Lipoproteins, HDL | 1 | 2024 | 676 | 0.170 |
Why?
|
Viremia | 1 | 2022 | 707 | 0.170 |
Why?
|
Stillbirth | 2 | 2021 | 368 | 0.160 |
Why?
|
Genotype | 7 | 2024 | 12990 | 0.150 |
Why?
|
Pregnancy Outcome | 3 | 2024 | 2922 | 0.150 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15501 | 0.150 |
Why?
|
Child | 19 | 2024 | 80156 | 0.150 |
Why?
|
Folic Acid | 1 | 2024 | 1323 | 0.150 |
Why?
|
Maternal-Fetal Exchange | 1 | 2019 | 461 | 0.140 |
Why?
|
Neural Tube Defects | 1 | 2019 | 255 | 0.140 |
Why?
|
Humans | 53 | 2024 | 761572 | 0.140 |
Why?
|
Specimen Handling | 1 | 2021 | 702 | 0.140 |
Why?
|
Receptors, KIR | 1 | 2016 | 110 | 0.130 |
Why?
|
Hair | 1 | 2019 | 498 | 0.130 |
Why?
|
Bone Density | 3 | 2024 | 3551 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10212 | 0.130 |
Why?
|
Erythrocytes | 1 | 2024 | 2413 | 0.120 |
Why?
|
Immunity, Humoral | 1 | 2019 | 606 | 0.120 |
Why?
|
Adolescent | 18 | 2024 | 88324 | 0.120 |
Why?
|
Cohort Studies | 11 | 2022 | 41493 | 0.120 |
Why?
|
Alu Elements | 1 | 2015 | 115 | 0.120 |
Why?
|
Congenital Abnormalities | 1 | 2019 | 709 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 2 | 2019 | 1844 | 0.110 |
Why?
|
Uganda | 3 | 2024 | 1332 | 0.110 |
Why?
|
Abortion, Spontaneous | 1 | 2019 | 533 | 0.110 |
Why?
|
Adult | 22 | 2024 | 221203 | 0.110 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.110 |
Why?
|
Histocompatibility Antigens | 1 | 2014 | 464 | 0.110 |
Why?
|
Young Adult | 14 | 2024 | 59255 | 0.110 |
Why?
|
Inflammation | 2 | 2024 | 10773 | 0.110 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3156 | 0.110 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2012 | 557 | 0.100 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2015 | 330 | 0.100 |
Why?
|
HIV Antibodies | 1 | 2019 | 1303 | 0.100 |
Why?
|
Africa South of the Sahara | 3 | 2020 | 744 | 0.100 |
Why?
|
Child, Preschool | 10 | 2024 | 42230 | 0.100 |
Why?
|
Life Style | 1 | 2024 | 3917 | 0.100 |
Why?
|
Mothers | 2 | 2020 | 2198 | 0.100 |
Why?
|
Medication Adherence | 3 | 2019 | 2176 | 0.100 |
Why?
|
Cytidine Deaminase | 1 | 2013 | 243 | 0.090 |
Why?
|
Parathyroid Hormone | 1 | 2017 | 1803 | 0.090 |
Why?
|
Marijuana Smoking | 1 | 2013 | 258 | 0.090 |
Why?
|
Executive Function | 2 | 2017 | 1392 | 0.090 |
Why?
|
DNA, Viral | 1 | 2017 | 2202 | 0.090 |
Why?
|
Alanine | 2 | 2024 | 609 | 0.090 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2011 | 269 | 0.080 |
Why?
|
Blood Glucose | 1 | 2024 | 6391 | 0.080 |
Why?
|
Gene Frequency | 1 | 2016 | 3606 | 0.080 |
Why?
|
Prospective Studies | 6 | 2024 | 54426 | 0.080 |
Why?
|
Central Nervous System Diseases | 1 | 2013 | 520 | 0.080 |
Why?
|
Somatomedins | 1 | 2009 | 179 | 0.080 |
Why?
|
Pregnant Women | 2 | 2023 | 566 | 0.080 |
Why?
|
Fractures, Bone | 1 | 2020 | 2046 | 0.070 |
Why?
|
Patient Selection | 1 | 2020 | 4244 | 0.070 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2009 | 208 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2017 | 1388 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6344 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 2011 | 1023 | 0.070 |
Why?
|
Male | 20 | 2024 | 360842 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3801 | 0.060 |
Why?
|
Self Report | 1 | 2016 | 3725 | 0.060 |
Why?
|
Alleles | 1 | 2016 | 6864 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2016 | 15936 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2021 | 4420 | 0.060 |
Why?
|
Africa, Southern | 1 | 2024 | 59 | 0.060 |
Why?
|
Vitamin D | 1 | 2017 | 3303 | 0.060 |
Why?
|
Disease Progression | 5 | 2019 | 13510 | 0.050 |
Why?
|
RNA | 2 | 2024 | 2726 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4369 | 0.050 |
Why?
|
Metabolomics | 2 | 2023 | 1659 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2024 | 397 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2024 | 22176 | 0.050 |
Why?
|
Risk Factors | 4 | 2024 | 74213 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.050 |
Why?
|
United States | 7 | 2022 | 72335 | 0.050 |
Why?
|
Lactation | 1 | 2024 | 397 | 0.050 |
Why?
|
Zimbabwe | 1 | 2022 | 135 | 0.050 |
Why?
|
Receptors, CCR | 1 | 2021 | 37 | 0.050 |
Why?
|
Africa | 1 | 2024 | 709 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14607 | 0.050 |
Why?
|
Prolactin | 1 | 2023 | 625 | 0.050 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4028 | 0.050 |
Why?
|
Ritonavir | 1 | 2022 | 329 | 0.040 |
Why?
|
DNA Methylation | 1 | 2015 | 4399 | 0.040 |
Why?
|
14-3-3 Proteins | 1 | 2021 | 220 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 6312 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2023 | 754 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2012 | 21017 | 0.040 |
Why?
|
Quinolones | 1 | 2022 | 378 | 0.040 |
Why?
|
Fertilization | 1 | 2020 | 199 | 0.040 |
Why?
|
Creatinine | 1 | 2024 | 1899 | 0.040 |
Why?
|
Progesterone | 1 | 2023 | 742 | 0.040 |
Why?
|
Nevirapine | 1 | 2019 | 273 | 0.040 |
Why?
|
Infant Formula | 1 | 2020 | 194 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2019 | 303 | 0.040 |
Why?
|
Absorptiometry, Photon | 1 | 2024 | 1738 | 0.040 |
Why?
|
HIV Integrase Inhibitors | 1 | 2019 | 165 | 0.040 |
Why?
|
India | 1 | 2024 | 2348 | 0.040 |
Why?
|
Inflammasomes | 1 | 2021 | 526 | 0.030 |
Why?
|
Botswana | 1 | 2019 | 1048 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2019 | 978 | 0.030 |
Why?
|
Prevalence | 3 | 2019 | 15732 | 0.030 |
Why?
|
Proviruses | 1 | 2017 | 313 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2012 | 4878 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2011 | 1998 | 0.030 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 63 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2103 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2020 | 1258 | 0.030 |
Why?
|
Bone Development | 1 | 2017 | 472 | 0.030 |
Why?
|
HLA-C Antigens | 1 | 2014 | 140 | 0.030 |
Why?
|
Puberty | 1 | 2017 | 501 | 0.030 |
Why?
|
Weight Gain | 1 | 2024 | 2348 | 0.030 |
Why?
|
Sexual Partners | 1 | 2018 | 796 | 0.030 |
Why?
|
Health Resources | 1 | 2020 | 935 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2199 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2014 | 317 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2021 | 1755 | 0.030 |
Why?
|
Microglia | 1 | 2021 | 1361 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4544 | 0.030 |
Why?
|
Gestational Age | 1 | 2021 | 3577 | 0.020 |
Why?
|
Fetus | 1 | 2019 | 1863 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2024 | 3617 | 0.020 |
Why?
|
Virus Replication | 1 | 2019 | 2435 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4853 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2020 | 2199 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2872 | 0.020 |
Why?
|
Mother-Child Relations | 1 | 2015 | 495 | 0.020 |
Why?
|
HLA Antigens | 1 | 2016 | 1328 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8633 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 64684 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 7054 | 0.020 |
Why?
|
HIV | 1 | 2015 | 1582 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26127 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5872 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2016 | 2201 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5821 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7827 | 0.020 |
Why?
|
Caregivers | 1 | 2017 | 2238 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 2013 | 1190 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2021 | 7858 | 0.010 |
Why?
|
Middle Aged | 4 | 2022 | 220920 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6180 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 6992 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6815 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6484 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12690 | 0.010 |
Why?
|
Aging | 1 | 2021 | 8711 | 0.010 |
Why?
|
Germ-Line Mutation | 1 | 2009 | 1858 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2012 | 17904 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12947 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12059 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39107 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 80646 | 0.010 |
Why?
|
Genetic Variation | 1 | 2009 | 6567 | 0.010 |
Why?
|
Aged | 2 | 2019 | 169310 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 30054 | 0.000 |
Why?
|
Concepts
(191)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_